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Public health surveillance has been defined as the ongoing,
systematic collection, analysis, interpretation, and feedback of
outcome-specific data used for public health practice (1).
Laboratory reports are critical to public health surveillance
because they initiate investigations of cases of reportable
diseases or outbreaks of infections. The current system of
laboratory reporting, which often relies on paper reports
delivered by mail, is slow and incomplete. Electronic laboratory-
based reporting (ELR) is likely to be more timely and complete
(2). A number of challenges must be addressed before ELR can be
used effectively, but recent activities are encouraging, and new
opportunities for ELR implementation have arisen.
ELR Challenges
The laboratory landscape is changing. Large national and
regional laboratories have developed advanced information
technology (IT) capabilites and use standardized test codes,
making ELR possible. However, many smaller laboratories do
not have the technology necessary for ELR. Additionally, many
states have reporting regulations that are not structured for
electronic reporting, and health department staff often have
limited knowledge of electronic data interchange technology.  In
the past, public health agencies have focused more on
epidemiology and statistics, and less on IT.
ELR Activities
In 1997, the Centers for Disease Control and Prevention
(CDC) and other public health partners sponsored a meeting at
which standards for pilot implementation of ELR were
determined (3) (i.e., the electronic message format uses the
national clinical information standard Health Level Seven
[HL7](4), tests are coded with the Logical Observation
Identifiers Names and Codes [LOINC] (5), and results are coded
with the Systemized Nomenclature for Medicine [SNOMED](6)
terminology. At a follow-up meeting in 1999 with broader
participation from informatics specialists and representatives
from the laboratory community, the group affirmed the ELR
approach and planned further implementations (7).
ELR pilot activities have provided valuable lessons. In
Hawaii, ELR increased the number of reports 2.3 times, reports
arrived 4 days earlier, and demographic data were more
complete (2). In Washington and Texas, the feasibility of using
HL7 with standardized codes was demonstrated. In Minnesota
and Oregon, commercial off-the-shelf messaging software has
been used to receive standard electronic messages from national
laboratories. Other projects are under way at various sites.
Recently, CDC initiated the National Electronic Disease
Surveillance System (NEDSS) to improve public health
surveillance through enhanced IT infrastructure and
capability. Electronic messaging for clinical and laboratory
reports is one of eight elements that will be implemented by
using the NEDSS information architecture (8).
ELR Opportunities
A few large national laboratories contribute a substantial
proportion of reports to health departments. Focusing on these
laboratories and ensuring their ELR capacity early will likely
produce important results. Some of these laboratories can report
from a single data repository, which may allow more efficient and
possibly enhanced surveillance. Another component of the
NEDSS architecture, Web-based reporting, may permit smaller
laboratories to more easily participate in ELR. CDC is working
closely with standards organizations to ensure that public
health needs are represented in national data standards.
Conclusion
Effective use of ELR will require overcoming several
challenges: standardizing message format and coding, develop-
ing policy, and improving knowledge and skills for implemen-
tation. As part of the larger surveillance system integration
initiative of NEDSS, ELR will likely be more accessible to
public health partners and providers of public health reports.
Opportunities exist for developing public-private partner-
ships with national laboratories. Public health issues are
being incorporated in national standards development. NEDSS
support to states will identify current ELR capabilities and
provide an opportunity for health officials to examine IT issues.
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